|1.||Fu, Yang-Xin: 9 articles (05/2010 - 02/2002)|
|2.||Pfeffer, Klaus: 8 articles (06/2012 - 07/2002)|
|3.||Hehlgans, Thomas: 6 articles (06/2012 - 07/2002)|
|4.||Tamada, Koji: 4 articles (09/2015 - 02/2002)|
|5.||Männel, Daniela N: 4 articles (03/2011 - 07/2002)|
|6.||Nedospasov, Sergei A: 4 articles (03/2011 - 07/2002)|
|7.||Tumanov, Alexei V: 3 articles (03/2011 - 04/2007)|
|8.||Ware, Carl F: 3 articles (05/2008 - 10/2002)|
|9.||Stopfer, Peter: 3 articles (01/2008 - 07/2002)|
|10.||Anders, Robert A: 3 articles (05/2007 - 03/2004)|
|1.||Graft vs Host Disease (Graft-Versus-Host Disease)
02/01/2002 - "Previous studies have shown that blockade of LIGHT, a T cell costimulatory molecule belonging to the TNF superfamily, by soluble lymphotoxin beta receptor-Ig (LTbetaR-Ig) inhibits the cytotoxic T lymphocyte (CTL) response to host antigenic disparities and ameliorates lethal graft-versus-host disease (GVHD) in a B6 to BDF1 mouse model. "
09/27/2007 - "Previous studies have shown that blockade of LIGHT, a T-cell costimulatory molecule belonging to the tumor necrosis factor (TNF) superfamily, by soluble lymphotoxin beta receptor-Ig (LTbetaR-Ig) inhibited the development of graft-versus-host disease. "
04/15/2005 - "Inhibition of LIGHT (a cellular ligand for herpes virus entry mediator and lymphotoxin receptor)/herpes simplex virus entry mediator (HVEM) and LIGHT/lymphotoxin beta receptor (LT beta R) interactions decreases mortality in MHC class I and II disparate graft-vs-host disease (GVHD). "
05/01/2007 - "Decoy lymphotoxin beta receptor (LTbetaR) has potent immune inhibitory activities and thus represents a promising biologic for the treatment of inflammation, autoimmune diseases, and graft-versus-host disease (GVHD). "
06/01/2012 - "Lymphotoxin-beta receptor activation on macrophages ameliorates acute DSS-induced intestinal inflammation in a TRIM30α-dependent manner."
04/01/2004 - "Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis."
01/01/2008 - "Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes."
10/01/2002 - "The lymphotoxin-beta receptor (LTbetaR) plays critical roles in inflammation and lymphoid organogenesis through activation of NF-kappaB. "
09/01/2012 - "Lymphotoxin-beta receptor blockade induces inflammation and fibrosis in tolerized cardiac allografts."
|3.||Melanoma (Melanoma, Malignant)
02/15/1997 - "Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells."
04/15/2005 - "However, in this study, we show that human melanoma cells express LIGHT/TNFSF14, a ligand of herpesvirus entry mediator on T cells and of lymphotoxin beta receptor on stromal cells. "
05/30/2008 - "Of the three receptors that require NIK for activation of NF-kappaB, only the lymphotoxin-beta receptor (LTbeta-R) is expressed in melanoma. "
05/30/2008 - "The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells."
|5.||Hodgkin Disease (Hodgkin's Disease)
01/01/1999 - "Among them are also molecules belonging to superfamily of tumor necrosis factor receptor (TNFR) which beside CD30 include CD27, CD40, TNFR-I and -II, Fas (CD95), OX40, 4-1BB (CDw137), nerve growth factor receptor, lymphotoxin-beta receptor, Apo3/DR3/Ws1-1/lymphocyte associated receptor of death, DR4, DR5/TNF-related apoptosis-inducing ligand, osteoprotegerin, and TNFR-related 2. CD30 recognized originally on Reed-Sternberg cells of Hodgkin's lymphoma became of interest in studies of Th1 and Th2 cell differentiation. "
|1.||Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|4.||Member 14 Tumor Necrosis Factor Receptors
|5.||TNF-Related Apoptosis-Inducing Ligand
|6.||Type I Tumor Necrosis Factor Receptors
|7.||Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)
|9.||NF-kappa B (NF-kB)
|10.||Immunoglobulin G (IgG)
|2.||Homologous Transplantation (Allograft)
|3.||Heterologous Transplantation (Xenotransplantation)